Explore Propofol, a fast-acting intravenous anesthetic used for induction and maintenance of anesthesia and sedation. Understand its benefits, dosage, and potential side effects.
Browse our catalog for available pharmaceutical products and competitive pricing.
Propofol is a short-acting, intravenous hypnotic agent used for the induction and maintenance of general anesthesia, and for sedation. It belongs to a class of drugs known as alkylphenols. Its rapid onset and quick recovery profile make it a cornerstone in modern anesthesiology and critical care. Unlike many other anesthetics, Propofol is not a barbiturate, opioid, or benzodiazepine, though it shares some similarities in its effects on the central nervous system. It is commonly supplied as a white, oil-in-water emulsion, giving it a milky appearance, hence its nickname "milk of amnesia."
The development of Propofol began in the 1970s, with its initial formulation proving problematic due to severe allergic reactions. A more stable and less reactive formulation, based on a soy oil/egg lecithin/glycerol emulsion, was successfully developed and first introduced clinically in Europe in 1986 and in the United States in 1989. Since then, it has largely replaced many older intravenous anesthetics, such as thiopental, due to its favorable pharmacokinetic and pharmacodynamic properties, including a smoother recovery with less post-operative nausea and vomiting. Its widespread adoption underscores its efficacy and safety profile when administered by trained professionals.
As an essential medication in the field of anesthesiology, Propofol is categorized under the Anatomical Therapeutic Chemical (ATC) classification system with the code N01AX10, falling under N01 (Anesthetics) and N01A (General Anesthetics). This classification highlights its primary role as a general anesthetic. Its distinctive properties, including rapid metabolism and minimal accumulation even after prolonged infusions, contribute to its utility in diverse clinical settings, from routine surgical procedures to extended sedation in intensive care units.
The primary mechanism of action of Propofol involves potentiation of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) at GABA-A receptors in the central nervous system (CNS). By binding to specific sites on the GABA-A receptor complex, Propofol increases the influx of chloride ions into neurons. This hyperpolarizes the neuronal membrane, making it less excitable and effectively inhibiting neuronal activity. The result is a dose-dependent depression of the CNS, leading to sedation, hypnosis, and anesthesia.
Beyond its primary effect on GABA-A receptors, Propofol is also believed to have other modulatory effects, although these are considered secondary to its GABAergic action. These include modulation of glycine receptors, inhibition of the N-methyl-D-aspartate (NMDA) receptor, and possible effects on voltage-gated sodium channels. These additional mechanisms may contribute to the diverse pharmacological effects of Propofol, including its antiemetic properties and potential neuroprotective effects, further solidifying its role as a versatile anesthetic agent.
Propofol is a highly versatile anesthetic agent with a wide range of medical applications, primarily centered around inducing and maintaining states of reduced consciousness. Its rapid onset and recovery profile make it suitable for various procedures requiring controlled sedation or general anesthesia.
The dosage of Propofol is highly individualized and depends on the patient's age, weight, physical status, the type of procedure, and the desired level of sedation or anesthesia. It is always administered intravenously, typically as a bolus for induction and then as a continuous infusion for maintenance. Due to its potent effects and narrow therapeutic index, Propofol should only be administered by healthcare professionals trained in administering general anesthesia or managing critically ill patients, with immediate availability of resuscitation equipment.
| Indication | Typical Dose | Frequency | Route |
|---|---|---|---|
| Induction of General Anesthesia (Adults) | 1.5-2.5 mg/kg | Single bolus | Intravenous |
| Maintenance of General Anesthesia (Adults) | 100-200 mcg/kg/min | Continuous infusion | Intravenous |
| ICU Sedation (Adults) | 5-50 mcg/kg/min | Continuous infusion | Intravenous |
| Procedural Sedation (Adults) | 0.5-1 mg/kg bolus, then 25-75 mcg/kg/min infusion | As needed / Continuous | Intravenous |
Important: Always follow your prescriber instructions. Dosages vary by weight, age, and condition, and may require titration based on patient response and clinical endpoints such as BIS monitoring or clinical signs of depth of anesthesia/sedation. Special consideration must be given to elderly, debilitated, or hypovolemic patients, who may require significantly reduced dosages of Propofol.
While Propofol is generally well-tolerated, it can cause a range of side effects, some of which can be significant. The incidence and severity of these effects are often dose-dependent and influenced by the patient's overall health.
Propofol can interact with various medications, potentially altering its effects or increasing the risk of adverse reactions. It is crucial to inform healthcare providers about all medications, supplements, and herbal products being taken prior to Propofol administration.
Medical Disclaimer: This information is for educational purposes only. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. The use of Propofol requires strict medical supervision.
Propofol is generally not recommended for long-term sedation (beyond 24-48 hours) in high doses, especially in critically ill patients, due to the risk of developing Propofol Infusion Syndrome (PRIS). For prolonged sedation, clinicians often switch to alternative agents to minimize this serious risk. However, it can be used for several days in carefully monitored ICU settings at lower doses.
No, Propofol is administered intravenously and is not taken orally with food. Its administration is strictly controlled within a medical setting, typically in operating rooms, intensive care units, or during diagnostic procedures. Dietary intake does not affect its action, as it bypasses the digestive system entirely.
Propofol is administered by healthcare professionals in a controlled medical environment. Patients do not self-administer or miss doses in the traditional sense. Its administration is carefully titrated to achieve a desired clinical effect, and any adjustments or interruptions would be managed by the attending medical team based on the patient's needs and response.
Propofol is a potent prescription medication that requires professional administration and is not available for purchase by the general public. It can only be obtained and administered by licensed medical professionals (e.g., anesthesiologists, intensivists) within hospitals, clinics, or other authorized healthcare facilities. Any offers to "buy Propofol" or obtain "Propofol for sale" outside of these legitimate medical channels should be treated with extreme caution and are likely illegal or unsafe.